Tislelizumab plus chemotherapy in metastatic extramammary Paget disease after surgery: a case report

Extramammary Paget disease (EMPD) is a rare epithelial adenocarcinoma in apocrine-gland rich skin, involving the vulva, the scrotum, and the penis. with distant metastases and a poor prognosis. Local EMPD patients generally have a good prognosis, with expected 5-year survival of 60%–92%, but distant...

Full description

Bibliographic Details

Published in:	Frontiers in Oncology
Main Authors:	Dongxing Wang, Chuang Huang, Dongming Wang, Dehui Chang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-10-01
Subjects:	extramammary Paget’s disease immunotherapy tislelizumab chemotherapy surgery
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1402490/full